Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans

Role of impaired gastric accommodation to a meal in functional dyspepsia

Tack, J. F., Piessevaux, H. H., Coulie, B. J., Caenepeel, P., & Janssens, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70012-5 · Cited by 1,061 · see citing works

Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654 · see citing works

Glucagon-like peptide-1: a potent regulator of food intake in humans

Gutzwiller, J.-P., Göke, B., Drewe, J., Hildebrand, P., Ketterer, S., Handschin, D., Winterhalder, R., Conen, D., & Beglinger, C. (1999) · Gut · doi:10.1136/gut.44.1.81 · Cited by 571 · see citing works

Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide

Fehmann, H. C., Göke, R., & Göke, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 527 · see citing works

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

Gutzwiller, J., Drewe, J., Göke, B., Schmidt, H., Rohrer, B., Lareida, J., & Beglinger, C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1541 · Cited by 521 · see citing works

Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432 · see citing works

Gastric emptying and release of incretin hormones after glucose ingestion in humans.

Schirra, J., Katschinski, M., Weidmann, C., Schäfer, T., Wank, U., Arnold, R., & Göke, B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118411 · Cited by 426 · see citing works

Standardization of Barostat Procedures for Testing Smooth Muscle Tone and Sensory Thresholds in the Gastrointestinal Tract

Whitehead, W. E., & Delvaux, M. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018885028501 · Cited by 387 · see citing works

Gastric Tone Measured by an Electronic Barostat in Health arid Postsurgical Gastroparesis

Azpiroz, F., & Malagelada, J. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90967-x · Cited by 358 · see citing works

Glucagon-Like Peptide I Receptors in the Subfornical Organ and the Area Postrema Are Accessible to Circulating Glucagon-Like Peptide I

Ørskov, C., Poulsen, S. S., Mørten, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.6.832 · Cited by 303 · see citing works

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I

Orskov, C., Poulsen, S. S., Moller, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diabetes.45.6.832 · Cited by 303 · see citing works

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

Schirra, J., Sturm, K., Leicht, P., Arnold, R., Göke, B., & Katschinski, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1349 · Cited by 265 · see citing works

Gastric wall tension determines perception of gastric distention

Distrutti, E., Azpiroz, F., Soldevilla, A., & Malagelada, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70006-5 · Cited by 238 · see citing works

Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow

Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g984 · Cited by 194 · see citing works

Modulation of gastric sensory and motor functions by nitrergic and α2-adrenergic agents in humans

Thumshirn, M., Camilleri, M., Choi, M., & Zinsmeister, A. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70179-4 · Cited by 186 · see citing works

Adrenergic modulation of human colonic motor and sensory function

Bharucha, A. E., Camilleri, M., Zinsmeister, A. R., & Hanson, R. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.5.g997 · Cited by 177 · see citing works

Hyperglycaemia stimulates pyloric motility in normal subjects.

Fraser, R. J., Horowitz, M., & Dent, J. (1991) · Gut · doi:10.1136/gut.32.5.475 · Cited by 176 · see citing works

Gastric tone determines the sensitivity of the stomach to distention

Notivol, R., Coffin, B., Azpiroz, F., Mearin, F., Serra, J., & Malagelada, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90057-8 · Cited by 175 · see citing works

Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus

Frank, J. W., Saslow, S. B., Camilleri, M., Thomforde, G. M., Dinneen, S. F., & Rizza, R. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90382-8 · Cited by 157 · see citing works

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.

Wettergren, A., Wøjdemann, M., Meisner, S., Stadil, F., & Holst, J. J. (1997) · Gut · doi:10.1136/gut.40.5.597 · Cited by 153 · see citing works

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gut · doi:10.1136/gut.46.5.622 · Cited by 145 · see citing works

Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man

Wettergren, A., Petersen, H., ørskov, C., Christiansen, J., Sheikh, S. P., & Holst, J. J. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409092462 · Cited by 133 · see citing works

Glucagon-like Peptide-1 Retards Gastric Emptying and Small Bowel Transit in the Rat (Effect Mediated Through Central or Enteric Nervous Mechanisms)

Tolessa, T., Gutniak, M., Holst, J. J., Efendić, S., & Hellström, P. M. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026678925120 · Cited by 123 · see citing works

Relations among intragastric pressure, postcibal perception, and gastric emptying.

Moragas, G., Azpiroz, F., Pavía, J., & Malagelada, J. (1993) · American Journal of Physiology · doi:10.1152/ajpgi.1993.264.6.g1112 · Cited by 120 · see citing works

Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans

Zerbib, F., Varannes, S. B. D., Scarpignato, C., Leray, V., D’Amato, M., Rozé, C., & Galmiche, J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.6.g1266 · Cited by 112 · see citing works

Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.

Schirra, J. R. J., Kuwert, P., Wank, U., Leicht, P., Arnold, R., Göke, B., & Katschinski, M. (1997) · PubMed · Cited by 100 · see citing works

Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects

Hebbard, G., Sun, W. M., Dent, J., & Horowitz, M. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199603000-00005 · Cited by 97 · see citing works

Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion

Hebbard, G. S., Samsom, M., SUN, W. M., Dent, J., & Horowitz, M. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.5.g814 · Cited by 93 · see citing works

Gastric Meal Accommodation Studied by Ultrasound in Diabetes: Relation to Vagal Tone

Undeland, K. A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850170784 · Cited by 81 · see citing works

Glucagon-like Peptide-1, A Gastrointestinal Hormone with a Pharmaceutical Potential

Holst, J. J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401163238 · Cited by 75 · see citing works

The Effects of Glucagon-like Peptide-I (GLP-I) on Hormone Secretion from Isolated Human Pancreatic Islets

Fehmann, H. C., Hering, B. J., Wolf, M.-J., Brandhorst, H., Brandhorst, D., Bretzel, R. G., Federlin, K., & Göke, B. (1995) · Pancreas · doi:10.1097/00006676-199508000-00014 · Cited by 67 · see citing works

Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus

Schirra, J. R. J., Leicht, P., Hildebrand, P., Beglinger, C., Arnold, R., Göke, B., & Katschinski, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560177 · Cited by 65 · see citing works

Effects of Fasting, Refeeding, and Intraluminal Triglyceride on Proglucagon Expression in Jejunum and Ileum

Hoyt, E. C., Lund, P. K., Winesett, D. E., Fuller, C. R., Ghatei, M. A., Bloom, S. R., & Ulshen, M. H. (1996) · Diabetes · doi:10.2337/diab.45.4.434 · Cited by 59 · see citing works

Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance

Byrne, M. M., Gliem, K., Wank, U., Arnold, R., Katschinski, M., Polonsky, K. S., & Göke, B. (1998) · Diabetes · doi:10.2337/diab.47.8.1259 · Cited by 55 · see citing works

Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia

Lingenfelser, T., SUN, W. M., Hebbard, G., Dent, J., & Horowitz, M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.3.g711 · Cited by 44 · see citing works

Effect of CCK on proximal gastric motor function in humans

Straathof, J. W., Mearadji, B., Lamers, C. B. H. W., & Masclee, A. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.5.g939 · Cited by 39 · see citing works

Effects of GLP-1 on Gastric Emptying, Antropyloric Motility, and Transpyloric Flow in Response to a Nonnutrient Liquid

Anvari, M., Paterson, C. A., Daniel, E. E., & McDonald, T. J. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018863716749 · Cited by 36 · see citing works

Abnormal Intragastric Distribution of a Liquid Nutrient Meal in Patients with Diabetes Mellitus

Troncon, L. E. A., Rosa-e-Silva, L., de Oliveira, R. B., Iazigi, N., Gallo, L. C., & Foss, M. C. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018834025351 · Cited by 33 · see citing works

Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance

Byrne, M. M., Gliem, K., Wank, U., Arnold, R., Katschinski, M., Polonsky, K. S., & Göke, B. (1998) · Diabetes · doi:10.2337/diabetes.47.8.1259 · Cited by 32 · see citing works

Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia

Byrne, Pluntke, Wank, Schirra, Arnol'd, �. �., Göke, & Katschinski (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00240.x · Cited by 31 · see citing works

Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects

Verhagen, M. A. M. T., Rayner, C. K., Andrews, J. M., Hebbard, G., Doran, S., Samsom, M., & Horowitz, M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.3.g761 · Cited by 26 · see citing works

Effect of gastrin on proximal gastric motor function in humans

Mearadji, Straathof, Lamers, & Masclee (1999) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1999.00168.x · Cited by 26 · see citing works

Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells

Rodier, G., Magous, R., Mochizuki, T., Martínez, J., Nguyen, D. L., Balì, J.-P., BATAILLE, D., & Jarrousse, C. (1997) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050458 · Cited by 23 · see citing works

Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum

Hoyt, E. C., Lund, P. K., Winesett, D. E., et al. (1996) · Diabetes · doi:10.2337/diabetes.45.4.434 · Cited by 14 · see citing works

GLP-1(7-36)amide (GLP-1) is a physiological inhibitory modulator of interdigestive and postprandial fundic motility

Schirra, J. J., Craney, C., Nicolaus, M., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)83294-1 · Cited by 1 · see citing works

Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB

Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578 · see citing works

Ileal brake: a sensible food target for appetite control. A review

Maljaars, P. W. J., Peters, H. P. F., Mela, D. J., & Masclee, A. A. M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.07.018 · Cited by 451 · see citing works

Review article: the role of gastric motility in the control of food intake

Janssen, P., Berghe, P. V., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 347 · see citing works

Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS

van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0414 · Cited by 312 · see citing works

Effects of GLP-1 on appetite and weight

Shah, M., & Vella, A. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9289-5 · Cited by 352 · see citing works

Glucagon-like peptide 1(GLP-1) in biology and pathology

Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288 · see citing works

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

Schirra, J., Nicolaus, M., Roggel, R., Katschinski, M., Storr, M., Woerle, H. J., & Göke, B. (2005) · Gut · doi:10.1136/gut.2004.059741 · Cited by 275 · see citing works

Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity

Maselli, D. B., & Camilleri, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_496 · Cited by 248 · see citing works

Integrated Upper Gastrointestinal Response to Food Intake

Camilleri, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.023 · Cited by 247 · see citing works

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

Deane, A. M., Nguyen, N. Q., Stevens, J. E., Fraser, R. J., Holloway, R. H., Besanko, L. K., Burgstad, C. M., Jones, K. L., Chapman, M. J., Rayner, C. K., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1503 · Cited by 240 · see citing works

Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia

Delgado-Aros, S., Camilleri, M., Cremonini, F., Ferber, I. J., Stephens, D. A., & Burton, D. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.006 · Cited by 235 · see citing works

Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease

Piche, T., Varannes, S. B. D., Sacher‐Huvelin, S., Holst, J. J., Cuber, J. C., & Galmiche, J. P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50159 · Cited by 232 · see citing works

Peripheral Mechanisms in Appetite Regulation

Camilleri, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.09.016 · Cited by 215 · see citing works

Effects of Intravenous Glucagon-Like Peptide-1 on Gastric Emptying and Intragastric Distribution in Healthy Subjects: Relationships with Postprandial Glycemic and Insulinemic Responses

Little, T. J., Pilichiewicz, A. N., Russo, A., Phillips, L. K., Jones, K. L., Nauck, M. A., Wishart, J. M., Horowitz, M., & Feinle‐Bisset, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2220 · Cited by 214 · see citing works

Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not

Raun, K., von Voss, P., Gotfredsen, C. F., Golozoubova, V., Rolin, B. C., & Knudsen, L. B. (2006) · Diabetes · doi:10.2337/db06-0565 · Cited by 207 · see citing works

Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes

Vella, A. V., Bock, G., Giesler, P. D., Burton, D. B., Serra, D. B., Ligueros‐Saylan, M., Dunning, B. E., Foley, J. E., Rizza, R. A., & Camilleri, M. (2007) · Diabetes · doi:10.2337/db07-0136 · Cited by 200 · see citing works

Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes

Young, R. L., Sutherland, K., Pezos, N., Brierley, S. M., Horowitz, M., Rayner, C. K., & Blackshaw, L. A. (2009) · Gut · doi:10.1136/gut.2008.148932 · Cited by 189 · see citing works

Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis: Incretins, gastric emptying and metabolic control

Edholm, T., Degerblad, M., Grybäck, P., Hilsted, L., Holst, J. J., Jacobsson, H., Efendic, S., Schmidt, P. T., & Hellström, P. M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01554.x · Cited by 164 · see citing works

GLP‐1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome

Hellström, P. M., Näslund, E., Edholm, T., Schmidt, P. T., Kristensen, J., Theodorsson, E., Holst, J. J., & Efendic, S. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01079.x · Cited by 160 · see citing works

Independent influences of body mass and gastric volumes on satiation in humans

Delgado-Aros, S., Cremonini, F., Castillo, J. E., Chial, H. J., Burton, D. D., Ferber, I. J., & Camilleri, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.007 · Cited by 160 · see citing works

Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide

Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae719 · Cited by 157 · see citing works

The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications

Madsbad, S. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12119 · Cited by 146 · see citing works

The physiological role of GLP-1 in human: incretin, ileal brake or more?

Schirra, J. R. J., & Göke, B. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.018 · Cited by 146 · see citing works

Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/279530 · Cited by 138 · see citing works

Assessment of gastric accommodation: overview and evaluation of current methods

Schepper, H. U. D., Cremonini, F., Chitkara, D. K., & Camilleri, M. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00497.x · Cited by 133 · see citing works

Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin

He, Y. (2012) · Clinical Pharmacokinetics · doi:10.2165/11598080-000000000-00000 · Cited by 128 · see citing works

Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats

Chelikani, P. K., Haver, A. C., & Reidelberger, R. D. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00870.2004 · Cited by 128 · see citing works

Gastrointestinal satiety signals in humans — Physiologic roles for GLP-1 and PYY ?

Beglinger, C., & Degen, L. P. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.048 · Cited by 114 · see citing works

Gastric Sensorimotor Functions and Hormone Profile in Normal Weight, Overweight, and Obese People

Roque, M. I. V., Camilleri, M., Stephens, D. A., Jensen, M. D., Burton, D. D., Baxter, K. L., & Zinsmeister, A. R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.025 · Cited by 112 · see citing works

The gastrointestinal tract in hunger and satiety signalling

Tack, J. F., Verbeure, W., Mori, H., Schol, J., den Houte, K. V., Huang, I., Balsiger, L. M., Broeders, B., Colomier, E., Scarpellini, E., et al. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12097 · Cited by 106 · see citing works

Review article: a comparison of glucagon‐like peptides 1 and 2

Janssen, P., Rotondò, A., Mulè, F., & Tack, J. F. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12092 · Cited by 105 · see citing works

Effect of high fat-diet and obesity on gastrointestinal motility.

Mushref, M. A., & Srinivasan, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2012.11.01 · Cited by 105 · see citing works

Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans

Halim, M. A., Degerblad, M., Sundbom, M., Karlbom, U., Holst, J. J., Webb, D., & Hellström, P. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02006 · Cited by 103 · see citing works

Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes

ten Kulve, J. S., Veltman, D. J., van Bloemendaal, L., Barkhof, F., Drent, M. L., Diamant, M., & IJzerman, R. G. (2016) · Diabetes Care · doi:10.2337/dc15-0772 · Cited by 102 · see citing works

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

Irwin, N., McClean, P. L., O'Harte, F. P. M., Gault, V. A., Harriott, P., & Flatt, P. R. (2007) · Diabetologia · doi:10.1007/s00125-007-0692-2 · Cited by 101 · see citing works

Meal-Anticipatory Glucagon-Like Peptide-1 Secretion in Rats

Vahl, T. P., Drazen, D. L., Seeley, R. J., D’Alessio, D. A., & Woods, S. C. (2009) · Endocrinology · doi:10.1210/en.2009-1002 · Cited by 100 · see citing works

Digestive Adaptation with Intestinal Reserve: A Neuroendocrine-Based Operation for Morbid Obesity

Santoro, S., Malzoni, C. E., Velhote, M. C. P., Milléo, F. Q., Santo, M. A., Klajner, S., Damiani, D., & Maksoud, J. G. (2006) · Obesity Surgery · doi:10.1381/096089206778663841 · Cited by 99 · see citing works

Contribution of Ascites to Impaired Gastric Function and Nutritional Intake in Patients With Cirrhosis and Ascites

Aqel, B. A., Scolapio, J. S., Dickson, R. C., Burton, D. D., & Bouras, E. P. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00531-8 · Cited by 94 · see citing works

The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients

Flint, A., Kapitza, C., Hindsberger, C., & Zdravkovic, M. (2011) · Advances in Therapy · doi:10.1007/s12325-010-0110-x · Cited by 91 · see citing works

Gastric Sensorimotor Functions and Hormone Profile in Normal Weight, Overweight, and Obese People

Katzka, D. A. (2007) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70028-x · Cited by 91 · see citing works

Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP ‐ 1R activation

Pabreja, K., Mohd, M. A., Koole, C., Wootten, D. L., & Furness, S. G. B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12313 · Cited by 84 · see citing works

Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

Anandhakrishnan, A., & Korbonits, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i20.572 · Cited by 81 · see citing works

Effects of glucagon‐like peptide‐1 and feeding on gastric volumes in diabetes mellitus with cardio‐vagal dysfunction

Delgado-Aros, S., Vella, A. V., Camilleri, M., Low, P. A., Burton, D. D., Thomforde, G. M., & Stephens, D. A. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00422.x · Cited by 79 · see citing works

Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study

Acosta, A., Camilleri, M., Burton, D., O'Neill, J., Eckert, D., Carlson, P., & Zinsmeister, A. R. (2015) · Physiological Reports · doi:10.14814/phy2.12610 · Cited by 78 · see citing works

GLP‐1 regulates gastroduodenal motility involving cholinergic pathways

Schirra, J. R. J., Nicolaus, M., Woerle, H. J., Struckmeier, C. A., Katschinski, M., & Göke, B. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01246.x · Cited by 77 · see citing works

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes

D’Alessio, D. A., & Vahl, T. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2004 · Cited by 76 · see citing works

Fundic accommodation assessed by SPECT scanning: comparison with the gastric barostat

van den Elzen, B. D. J., Bennink, R. J., Wieringa, R. E., Tytgat, G. N. J., & Boeckxstaens, G. E. (2003) · Gut · doi:10.1136/gut.52.11.1548 · Cited by 72 · see citing works

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective

Michałowska, J. M., Miller‐Kasprzak, E., & Bogdański, P. (2021) · Nutrients · doi:10.3390/nu13020351 · Cited by 69 · see citing works

The effect of dipeptidyl peptidase‐4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double‐blind, placebo‐controlled crossover study

Vella, A. V., Bock, G., Giesler, P. D., Burton, D. B., Serra, D. B., Ligueros‐Saylan, M., Deacon, C. F., Foley, J. E., Rizza, R. A., & Camilleri, M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03235.x · Cited by 62 · see citing works

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes

Man, C. D., Bock, G., Giesler, P. D., Serra, D. B., Ligueros‐Saylan, M., Foley, J. E., Camilleri, M., TOFFOLO, G. M., Cobelli, C., Rizza, R. A., et al. (2008) · Diabetes Care · doi:10.2337/dc08-1512 · Cited by 62 · see citing works

GLP-1 based therapies: clinical implications for gastroenterologists

Smits, M. M., van Raalte, D. H., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., & Cahen, D. L. (2016) · Gut · doi:10.1136/gutjnl-2015-310572 · Cited by 61 · see citing works

Intestinal permeability in cirrhotic patients with and without ascites

Kalaitzakis, E., Johansson, J., Bjarnason, I., & Bjornsson, E. S. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510024278 · Cited by 50 · see citing works

Diabetes mellitus and gastric emptying: questions and issues in clinical practice

Samsom, M., Bharucha, A. E., Gerich, J. E., Herrmann, K., Limmer, J., Linke, R., Maggs, D. G., Schirra, J. R. J., Vella, A. V., Wörle, H., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.974 · Cited by 47 · see citing works

A model of GLP-1 action on insulin secretion in nondiabetic subjects

Dalla Man, C., Micheletto, F., Sathananthan, A., Rizza, R. A., Vella, A., & Cobelli, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00705.2009 · Cited by 45 · see citing works

Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice

Rotondo, A., Amato, A., Lentini, L., Baldassano, S., & Mulè, F. (2010) · Peptides · doi:10.1016/j.peptides.2010.09.028 · Cited by 44 · see citing works

Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss

Avraham, S. A., Hossein, J., Somri, F., Hawash, N., & Hochman, O. (2024) · Anaesthesia Reports · doi:10.1002/anr3.12278 · Cited by 43 · see citing works

Effects of asimadoline, a κ‐opioid agonist, on satiation and postprandial symptoms in health

Delgado-Aros, S., Chial, H. J., Cremonini, F., Ferber, I. J., McKinzie, S., Burton, D. D., & Camilleri, M. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01670.x · Cited by 43 · see citing works

GLP-1: benefits beyond pancreas

Muscogiuri, G., Cignarelli, A., Giorgino, F., Prodram, F., Santi, D., Tirabassi, G., Balercia, G., Modica, R., Faggiano, A., & Colao, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0137-y · Cited by 41 · see citing works

Extraglycemic effects of glp-1-based therapeutics: Addressing metabolic and cardiovascular risks associated with type 2 diabetes

Herzlinger, S., & Horton, E. S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.009 · Cited by 41 · see citing works

Pleiotropic Actions of the Incretin Hormones

McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 40 · see citing works

Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin

Lai, Z., Li, C., Liu, J., Kong, L., Wen, X., & Sun, H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.044 · Cited by 39 · see citing works

Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution

Santoro, S., Velhote, M. C. P., Malzoni, C. E., Milleo, F. Q., Klajner, S., & Campos, F. G. (2006) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802006000400004 · Cited by 39 · see citing works

Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1

Plummer, M. P., Jones, K. L., Cousins, C. E., Trahair, L. G., Meier, J. J., Chapman, M. J., Horowitz, M., & Deane, A. M. (2015) · Diabetes Care · doi:10.2337/dc14-3091 · Cited by 36 · see citing works

Effects of Resistant Starch Interventions on Metabolic Biomarkers in Pre-Diabetes and Diabetes Adults

Rashed, A. A., Saparuddin, F., Rathi, D.-N. G., Nasir, N. N. M., & Lokman, E. F. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.793414 · Cited by 35 · see citing works

Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis

Liu, H., Xiao, H., Lin, S., Zhou, H., Cheng, Y., Xie, B., & Xu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1372399 · Cited by 34 · see citing works

Glucagon-like Peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis

Yang, R., Zhang, L., Guo, J., Wang, N., Zhang, Q., Qi, Z., Wu, L., Qin, L., & Liu, T. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06302-y · Cited by 34 · see citing works

Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion

Witte, A.-B., Grybäck, P., Jacobsson, H., Näslund, E. B., Hellström, P. M., Holst, J. J., Hilsted, L., & Schmidt, P. T. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.537680 · Cited by 34 · see citing works

GLP-1: Broadening the incretin concept to involve gut motility

Hellström, P. M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.004 · Cited by 30 · see citing works

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2

Mulvihill, E. E. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000495 · Cited by 29 · see citing works

Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism

Vahl, T. P., & D’Alessio, D. A. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078991.96795.84 · Cited by 28 · see citing works

Gastrointestinal Hormones ☆

Gribble, F. M., Reimann, F. M., & Roberts, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00002-5 · Cited by 27 · see citing works

Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro

Baldassano, S., Wang, G., Mulè, F., & Wood, J. D. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00333.2011 · Cited by 26 · see citing works

Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis

Kalaitzakis, E., Simrén, M., Abrahamsson, H., & Bjornsson, E. S. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600880898 · Cited by 26 · see citing works

Identification of expression and function of the glucagon-like peptide-1 receptor in colonic smooth muscle

May, A. T., Crowe, M. S., Blakeney, B. A., Mahavadi, S., Wang, H., Grider, J. R., & Murthy, K. S. (2018) · Peptides · doi:10.1016/j.peptides.2018.11.007 · Cited by 24 · see citing works

Peripheral mechanisms in the control of appetite and related experimental therapies in obesity

Camilleri, M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.011 · Cited by 23 · see citing works

New physiological effects of the incretin hormones GLP-1 and GIP.

Asmar, M. (2011) · PubMed · Cited by 21 · see citing works

Physiology of the Aerodigestive System and Aberrations in That System Resulting in Aspiration

DeMeo, M. T., & Bruninga, K. (2002) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710202600603 · Cited by 20 · see citing works

Is the GLP-1 system a viable therapeutic target for weight reduction?

Tong, J., & Sandoval, D. A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9170-8 · Cited by 19 · see citing works

Coexistence of gastric‐ and intestinal‐type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach

Otsuka, T., Tsukamoto, T., Mizoshita, T., Inada, K., Takenaka, Y., Kato, S., Yamamura, Y., Miki, K., & Tatematsu, M. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01809.x · Cited by 17 · see citing works

Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists

Gallwitz, B. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.247 · Cited by 17 · see citing works

Ultrasonographic assessment of the effect of metoclopramide, erythromycin, and exenatide on solid-phase gastric emptying in healthy cats

Husník, R., Gaschen, F. P., Fletcher, J. M., & Gaschen, L. E. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15787 · Cited by 16 · see citing works

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus

He, X., Zhao, W., Li, P., Zhang, Y., Li, G., Su, H., Lu, B., & Pang, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1483792 · Cited by 16 · see citing works

Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2- Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors

Syam, Y. M., El‐Karim, S. S. A., Nasr, T., Elseginy, S. A., Anwar, M. M., Kamel, M. M., & Ali, H. F. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557517666170828121018 · Cited by 15 · see citing works

Binge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius

Mukherjee, A., Hum, A., Gustafson, T. J., & Mietlicki‐Baase, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112830 · Cited by 11 · see citing works

DIGESTIVE PHYSIOLOGY OF THE PIG SYMPOSIUM: Potential applications of knowledge of gut chemosensing in pig production1

Liu, Y., Ipharraguerre, I. R., & Pettigrew, J. E. (2013) · Journal of Animal Science · doi:10.2527/jas.2012-6193 · Cited by 11 · see citing works

Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review

Gravina, A. G., Pellegrino, R., Izzo, M., Costanzo, I. D., Imperio, G., Landa, F., Tambaro, A., & Federico, A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050383 · Cited by 10 · see citing works

A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis

Liu, R., Li, Y., Ren-min, H., Jin, T., Deng, S., Wang, L., Zhang, N., Chen, J., Prud’homme, G. J., Jia, W. W.-G., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.131 · Cited by 10 · see citing works

Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications

Giorgino, F., Natalicchio, A., Leonardini, A., & Laviola, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.022 · Cited by 10 · see citing works

Stomachs: does the size matter? Aspects of intestinal satiety, gastric satiety, hunger and gluttony

Santoro, S. (2012) · Clinics · doi:10.6061/clinics/2012(04)01 · Cited by 10 · see citing works

Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes

Vella, A. V., & Smushkin, G. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4790 · Cited by 9 · see citing works

Concomitant variations of gastric tone and duodenal motility in humans: Results of a placebo-controlled study assessing octreotide and sumatriptan

Savoye, G., Bouin, M., Labbé, L., Mosni, G., Morcamp, P., Denis, P., & Ducrotte, P. R. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500335175 · Cited by 9 · see citing works

South American herbal extracts reduce food intake through modulation of gastrointestinal hormones in overweight and obese women

Celestino, M. M., Gomes, A. C., Botelho, P. B., Gambero, A., Mesquita, L. M. D. S., Vilegas, W., Ribeiro, M. L., & Mota, J. F. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.015 · Cited by 8 · see citing works

SANTORO S, VELHOTE MCP, MALZONI CE, MECHENAS ASG, DAMIANI D, MAKSOUD JG. Digestive Adaptation with Intestinal Reserve: A New Surgical Proposal for Morbid Obesity. Rev bras videocir 2004;2(3):130-138. Digestive Adaptation with Intestinal Reserve: A New Surgical Proposal for Morbid Obesity Adaptação Digestiva com Reserva Intestinal: Nova Proposta Cirúrgica para Obesidade Mórbida

Santoro, S., Carlos, M., Velhote, P., Malzoni, C. E., Mechenas, A. S. G., Damiani, D., & Maksoud, J. G. (2004) · Cited by 8 · see citing works

Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls

Meier, J. J. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i12.1874 · Cited by 8 · see citing works

Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis

Yamamichi, N., Shimamoto, T., Minatsuki, C., Yoshida, Y., Fujishiro, M., Kodashima, S., Kato, J., Goto, O., Ono, S., Niimi, K., et al. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-140 · Cited by 7 · see citing works

Sodium Glucose Transporter, Type 2 (SGLT2) Inhibitors (SGLT2i) and Glucagon-Like Peptide 1-Receptor Agonists: Newer Therapies in Whole-Body Glucose Stabilization

Shepard, B. D., & ECELBARGER, C. A. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.005 · Cited by 7 · see citing works

Utilizing the GLP-1 signaling system to treat diabetes: Sorting through the pharmacologic approaches

D’Alessio, D. A., & Vahl, T. P. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0092-2 · Cited by 7 · see citing works

Role of Y2 receptors in the regulation of gastric tone in rats

Janssen, P., Verschueren, S., Rotondò, A., & Tack, J. F. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00404.2011 · Cited by 7 · see citing works

Glucagon-Like Peptide-1 and Diabetes

Monami, M. (2011) · Experimental Diabetes Research · doi:10.1155/2011/901954 · Cited by 7 · see citing works

Impact of Objective Colonic and Whole Gut Motility Data as Measured by Wireless Motility Capsule on Outcomes of Antireflux Surgery

Eriksson, S. E. S., Maurer, N., Zheng, P., Sarici, I. S., DeWitt, A. M., Riccardi, M., Jobe, B. A., & Ayazi, S. (2022) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000470 · Cited by 6 · see citing works

MOTILITY AND VISCERAL SENSATION Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans

Schirra, J., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2016)

Effects of GLP-1 on proximal gastric motor and sensory function in human

Wank, U., Schirra, J., Arnold, R., Göke, B., & Katschinski, M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)84834-8 · Cited by 4 · see citing works

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gut · doi:10.1136/gut.46.5.622 · Cited by 145 · see citing works

Effects of Glucagon-like Peptide-1-(7-36)amide (GLP-1) on Gastric Motor Function in Health and Diabetes: Potential Mechanism of Action

Aros, S. D. (2003) · TDX (Tesis Doctorals en Xarxa)

GLP-1 inhibits proximal gastric motility but enhances perception

Wank, U., Schirra, J. J., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)83300-4